Off-Label Drugs in Neonatology: Analyses Using Large Data Bases
نویسندگان
چکیده
منابع مشابه
Off-label uses of drugs in children.
As we approach the new millennium, very little has changed regarding the labeling of prescription drugs for use in infants and children. Along with pregnant women, infants and children remain therapeutic orphans. This condition is understandable because there are very few therapeutic indications that are unique to this patient population and the absolute quantities of drugs required by these pa...
متن کاملOff-label use of drugs in children.
The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an overwhelming number of drugs still have no information in ...
متن کاملOff-label drugs for weight management
The global pandemic of obesity and overweight now affects between 2.8 and 3.5 billion of the world population and shows no signs of abatement. Treatment for what is now recognized as a chronic disease includes pharmacotherapy, considered an essential component of comprehensive therapy. New drug discovery is robust, but the pace of the US Food and Drug Administration approval for obesity drugs h...
متن کاملoff-label and off-nccn guidelines uses of antineoplastic drugs in china.
to evaluate off-label and off-nccn guidelines uses of antineoplastic drugs in a major chinese hospital.totally 1122 patients were selected from july to december 2011. then, the off-label and off-nccn guidelines uses of antineoplastic drugs were analyzed.in 798 of 1122 patients (71.12%), drugs were used for off-label. in 317 of 1122 patients (28.25%), the drugs were prescribed for off-label and ...
متن کاملThe conundrum of off-label and unlicensed drug usage in neonatology.
“O desafio do uso seguro e adequado de medicamentos no período neonatal é intimidante e torna-se mais complexo pela notória falta de dados baseados em evidências para orientar a tomada de decisões. Os clínicos lutam com as escassas opções de medicamentos que não foram rigorosamente testados em recém-nascidos muito pequenos; o problema muitas vezes torna-se ainda mais complexo devido à inaceitav...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Pediatrics
سال: 2019
ISSN: 0022-3476
DOI: 10.1016/j.jpeds.2019.01.038